Nova blog
Visit our website
    Nova blog

    How in silico can help HTA

    Faster drug approvals based on less evidence mean new tools are needed to track cost-effectiveness. As regulators approve more drugs faster, healt ...

    Read more

    NOVA
    Mar 14, 2022
    in silico HTA
    A standout 2021 supports in silico trials

    2021 was a standout year for drug development. The US FDA appr ...

    Read more

    NOVA
    Feb 14, 2022
    in silico ebook
    Scoring data quality builds trust in in silico modeling

    A new generation of clinical research is arising, thanks to a profusion of health data and data-powered technologies such as in silico modeling. More data, by itself, does not guarantee better res ...

    Read more

    Giulio Foresto
    Jan 25, 2022
    data quality scoring
    The power of synthetic control arms

    Control arms are key to reliably determining whether a new treatment works better than what already exists. The data they generate – from trial patients who receive a placebo, the standard of care (SO ...

    Read more

    NOVA
    Dec 01, 2021
    in-silico insights SCA
    Mechanistic models and AI

    How two distinct, yet complementary approaches could revolutionize R&D Mechanistic modeling and artificial intelligence (AI) are both transforming medicine. AI is being increasingly applied to drug ...

    Read more

    NOVA
    Nov 24, 2021
    in-silico insights disease model AI
    • Visit our website